Randomized evaluation shows no reduction in major bleeding complications during robotic-assisted nephrectomy using hemostatic agents, implying limited benefit.
Routine use of hemostatic agents during RALPN does not appear to lower the risk for bleeding following surgery, as measured by the change in hemoglobin levels or major bleeding complications.
No takes yet. Share an insight, caveat, or question.
Lazarovich et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: